Advertisement

The Synovium and Its Role in Osteoarthritis

  • Arjen B. Blom
  • Wim B. van den Berg
Chapter
Part of the Topics in Bone Biology book series (TBB, volume 4)

Keywords

Osteophyte Formation Osteoarthritis Cartilage Synovial Macrophage Macrophage Depletion Rheumatoid Arthritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bakker AC, van de Loo FA, van Beuningen HM, Sime P, van Lent PL, van der Kraan PM, Richards CD, van den Berg WB (2001) Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage 9:128–136.PubMedCrossRefGoogle Scholar
  2. 2.
    Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B (2005) Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 64:1263–1267.PubMedCrossRefGoogle Scholar
  3. 3.
    van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB (1993) Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 52:185–191.PubMedCrossRefGoogle Scholar
  4. 4.
    van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB (1998) Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 6:306–317.PubMedCrossRefGoogle Scholar
  5. 5.
    Blom AB, van Lent PL, Holthuysen AE, van der Kraan PM, Roth J, van Rooijen N, van den Berg WB (2004) Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 12:627–635.PubMedCrossRefGoogle Scholar
  6. 6.
    Cecil DL, Johnson K, Rediske J, Lotz M, Schmidt AM, Terkeltaub R (2005) Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol 175: 8296–8302.PubMedGoogle Scholar
  7. 7.
    Chubinskaya S, Kuettner KE (2003) Regulation of osteogenic proteins by chondrocytes. Int J Biochem Cell Biol 35:1323–1340.PubMedCrossRefGoogle Scholar
  8. 8.
    Dreier R, Grassel S, Fuchs S, Schaumburger J, Bruckner P (2004) Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Exp Cell Res 297:303–312.PubMedCrossRefGoogle Scholar
  9. 9.
    Drinda S, Franke S, Ruster M, Petrow P, Pullig O, Stein G, Hein G (2005) Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis. Rheumatol Int 25:411–413.PubMedCrossRefGoogle Scholar
  10. 10.
    Frisbie DD, Ghivizzani SC, Robbins PD, Evans CH, McIlwraith CW (2002) Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 9:12–20.PubMedCrossRefGoogle Scholar
  11. 11.
    Fuchs S, Dankbar B, Wildenau G, Goetz W, Lohmann CH, Tibesku CO (2004) Expression of the CD44 variant isoform 5 in the human osteoarthritic knee joint: correlation with radiological, histomorphological, and biochemical parameters. J Orthop Res 22:774–780.PubMedCrossRefGoogle Scholar
  12. 12.
    Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP (2005) Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 64:834–838.PubMedCrossRefGoogle Scholar
  13. 13.
    Harvey AK, Stack ST, Chandrasekhar S (1993) Differential modulation of degradative and repair responses of interleukin-1-treated chondrocytes by platelet-derived growth factor. Biochem J 292:129–136.PubMedGoogle Scholar
  14. 14.
    Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA (2003) Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 48:2173–2177.PubMedCrossRefGoogle Scholar
  15. 15.
    Honorati MC, Meliconi R, Pulsatelli L, Cane S, Frizziero L, Facchini A (2001) High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology (Oxford) 40:522–527.CrossRefGoogle Scholar
  16. 16.
    Hsieh YS, Yang SF, Chu SC, Chen PN, Chou MC, Hsu MC, Lu KH (2004) Expression changes of gelatinases in human osteoarthritic knees and arthroscopic debridement. Arthroscopy 20:482–488.PubMedCrossRefGoogle Scholar
  17. 17.
    Ishii H, Tanaka H, Katoh K, Nakamura H, Nagashima M, Yoshino S (2002) Characterization of infiltrating T cells and Th1/Th2-type cytokines in the synovium of patients with osteoarthritis. Osteoarthritis Cartilage 10:277–281.PubMedCrossRefGoogle Scholar
  18. 18.
    Knudson CB, Knudson W (2001) Cartilage proteoglycans. Semin Cell Dev Biol 12:69–78.PubMedCrossRefGoogle Scholar
  19. 19.
    van Lent PL, van den Bersselaar L, van den Hoek AE, van de Ende M, Dijkstra CD, van Rooijen N, van de Putte LB, van den Berg WB (1993) Reversible depletion of synovial lining cells after intra-articular treatment with liposome-encapsulated dichloromethylene diphosphonate. Rheumatol Int 13:21–30.PubMedCrossRefGoogle Scholar
  20. 20.
    van Lent PL, Blom AB, van der Kraan P, Holthuysen AE, Vitters E, van Rooijen N, Smeets RL, Nabbe KC, van den Berg WB (2004) Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum 50:103–111.PubMedCrossRefGoogle Scholar
  21. 21.
    Loeser RF, Yammani RR, Carlson CS, Chen H, Cole A, Im HJ, Bursch LS, Yan SD (2005) Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis. Arthritis Rheum 52:2376–2385.PubMedCrossRefGoogle Scholar
  22. 22.
    van de Loo FA (2004) Inflammation-responsive promoters for fine-tuned gene therapy in rheumatoid arthritis. Curr Opin Mol Ther 6:537–545.PubMedGoogle Scholar
  23. 23.
    Marini S, Fasciglione GF, Monteleone G, Maiotti M, Tarantino U, Coletta M (2003) A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities. Clin Biochem 36:295–304.PubMedCrossRefGoogle Scholar
  24. 24.
    Mulherin D, Fitzgerald O, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39:115–124.PubMedCrossRefGoogle Scholar
  25. 25.
    Pagura SM, Thomas SG, Woodhouse LJ, Ezzat S, Marks P (2005) Circulating and synovial levels of IGF-I, cytokines, physical function and anthropometry differ in women awaiting total knee arthroplasty when compared to men. J Orthop Res 23:397–405.PubMedCrossRefGoogle Scholar
  26. 26.
    van Rooijen N, Sanders A, van den Berg TK (1996) Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J Immunol Methods 193:93–99.PubMedCrossRefGoogle Scholar
  27. 27.
    Rudolphi K, Gerwin N, Verzijl N, van der Kraan P, van den Berg W (2003) Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage 11:738–746.PubMedCrossRefGoogle Scholar
  28. 28.
    Saito I, Koshino T, Nakashima K, Uesugi M, Saito T (2002) Increased cellular infiltrate in inflammatory synovia of osteoarthritic knees. Osteoarthritis Cartilage 10:156–162.PubMedCrossRefGoogle Scholar
  29. 29.
    Sakkas LI, Scanzello C, Johanson N, Burkholder J, Mitra A, Salgame P, Katsetos CD, Platsoucas CD (1998) T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol 5:430–437.PubMedGoogle Scholar
  30. 30.
    Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Gotte M, Malle E, Schaefer RM, Grone HJ (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115:2223–2233.PubMedCrossRefGoogle Scholar
  31. 31.
    Scharstuhl A, Vitters EL, van der Kraan PM, van den Berg WB (2003) Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 48:3442–3451.PubMedCrossRefGoogle Scholar
  32. 32.
    Schmidt MB, Chen EH, Lynch SE (2006) A review of the effects of insulin-like growth factor and platelet-derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 14:403–412.PubMedCrossRefGoogle Scholar
  33. 33.
    Steenvoorden MM, Huizinga TW, Verzijl N, Bank RA, Ronday HK, Luning HA, Lafeber FP, Toes RE, DeGroot J (2006) Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 54:253–263.PubMedCrossRefGoogle Scholar
  34. 34.
    Tanaka M, Masuko-Hongo K, Kato T, Nishioka K, Nakamura H (2006) Suppressive effects of hyaluronan on MMP-1 and RANTES production from chondrocytes. Rheumatol Int 26:185–190.PubMedCrossRefGoogle Scholar
  35. 35.
    Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima T, Komiya S, Maruyama I (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48:971–981.PubMedCrossRefGoogle Scholar
  36. 36.
    Tibesku CO, Szuwart T, Ocken SA, Skwara A, Fuchs S (2005) Increase in the expression of the transmembrane surface receptor CD44v6 on chondrocytes in animals with osteoarthritis. Arthritis Rheum 52:810–817.PubMedCrossRefGoogle Scholar
  37. 37.
    Tchetverikov I, Lohmander LS, Verzijl N, Huizinga TW, TeKoppele JM, Hanemaaijer R, DeGroot J (2005) MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis 64:694–698.PubMedCrossRefGoogle Scholar
  38. 38.
    van den Berg WB, van der Kraan PM, Scharstuhl A, van Beunargen HM (2001) Growth factors and cartilage repair. Clin Orthop Relat Res 391 (suppl): S244–S250.PubMedCrossRefGoogle Scholar
  39. 39.
    Yamanishi Y, Boyle DL, Clark M, Maki RA, Tortorella MD, Arner EC, Firestein GS (2002) Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. J Immunol 168:1405–1412.PubMedGoogle Scholar
  40. 40.
    Zhang X, Mao Z, Yu C (2004) Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J Orthop Res 22:742–750.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2007

Authors and Affiliations

  • Arjen B. Blom
  • Wim B. van den Berg

There are no affiliations available

Personalised recommendations